FDA Investigator Samuel A Francis
Samuel A Francis has inspections in 1 countries as of 28 Mar 2024. Samuel A Francis has collaborated with a combined 1684 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
38
Last Inspection Date:
28 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Albert Thompson,
Alice S Tsao,
Althea A Williams,
Amber D Brodas,
Amy Kim,
Andrew Cohen,
Andrew F Cohen,
Andrew J Garufi,
Arduino Frankovic,
Ashley Defilippis,
Ashley Polizzotto,
Beau R Lamb,
Bernandica Tsculac Stern,
Bernardica T Sculac Stern,
Betty M Ng Lee,
Brandon J Kocurek,
Brandon R Boone,
Carrie E Jolly,
Chagai L Winoker,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher S Fields,
Dana A Razzano,
David R Delucia,
Debra D Devlieger,
Deep R Parikh,
Devon O Seymour,
Donald J Ullstrom,
Donald Ullstrom,
Ellen M Landis,
Emilio Z Azukwu,
Eric J Reisenauer,
Erica B Raphael,
Eufemia G Gonzalez,
Isaac N Baah,
Jackson Y See,
Jane Chen,
Jason Kwong,
Jeff M Uriarte,
Jennifer A Bazergui,
John E Aghadia,
Jose V Obando,
Joseph H Procopio,
Joseph Maselli,
Joshua D Lopez,
Joy A Matthias,
Joy P Matthias,
Joyce A Williams,
Juliana Falla,
Kevin A Gonzalez,
Kimberly A Coward,
Kristen C Jackson,
Kristen M Campbell,
Kwong P Lee,
Leroy Terrelonge,
Lirissia Mccoy,
Loretta J Miller,
LTJG Matthew R Palo,
Manhar Patel,
Manhar R Patel,
Marie Elena C Puleo,
Melinee C Minhas,
Melissa A Henaghan,
Melissa N Gregorio,
Meredith P Soehl, Investigator,
Michael R Dominick,
Milan S Mcgorty,
Morgan J Matthews,
Nasser Yazdani,
Natalie J Ayoub,
Patrick E Gainer,
Patty P Kaewussdangkul,
Paul M Gelfand,
Perez,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Raymond M Lam,
Robert E Moncayo,
Seemay A Lee,
Shantel S Brown,
Sonia E Ortiz,
State Agency,
Sunita Vij,
Suwaskie S Smith,
Tamara M Simpson,
Tawny L Colling,
Terrance P Nguyen,
Terry E Pierre,
Tracy M Portelli,
Valerie A Potopsingh,
Vashti E Bocker,
Wayne J Meyer,
Willy A Orantes,
Yuyan Liang,
Yvonne M Santiago,
Zameer Farouk
Samuel A Francis's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2021 | FDA 483 Response | Banner Smoked Fish, Inc. - Form 483R, 2021-07-11 |
June, 2021 | FDA 483 | Banner Smoked Fish, Inc. - Form 483, 2021-06-21 |
July, 2022 | EIR | AmerisourceBergen Drug Corporation - EIR, 2022-07-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more